A PROMISE FOR A HEALTHIER TOMORROW

Cefporesp200 mgF.C.Tablets

Cefporesp
Cefporesp
Available oral third generation cephalosporin used for a wide range of various infections.
Composition:

Each ?lm coated tablet contains: Cefpodoxime proxetil 260.90 mg (eq. to 200 mg of Cefpodoxime base).

Propertise:

• Cefporesp: is a semi-synthetic oral beta lactam antibiotic belonging oral third generation cephalosporins acting through inhibition of bacterial cell wall synthesis.

• Cefporesp: possesses in vitro bactericidal activity against numerous gram positive and gram negative bacteria and is stable in the presence of numerous beta lactamases.

Indications:

• Upper respiratory tract infections (e.g. tonsillitis, pharyngitis and otitis media).

• Lower respiratory tract infections (e.g. chronic or acute exacerbation of bronchitis and community acquired  pneumonia).

• Sexually transmitted infections (e.g. cervical,  urethral or  rectal gonorrhea in women).

• Skin and soft tissue infections ( Impetigo, skin abscess and carbuncles).

• Urinary tract infections (cystitis, pyelonephritis, ...). 

Dosage & Administration:

• Bronchitis and bacterial exacerbations: 200 mg every 12 hours for 10 days.

• Cervical, urethral and rectal gonorrhea in women: 200 mg as a single dose.

• Pharyngitis or tonsillitis: 100 mg every 12 hours for 5-10 days.

• Community acquired pneumonia: 200 mg every 12 hours for 14 days.

• Skin and soft tissue infections: 400 mg every 12 hours for 7-14 days.

• Uncomplicated urinary tract infections: 100 mg every 12 hours for 7 days.